HONG KONG – Over the next year, health authorities in China plan to renew their focus on biotech development and continue funding research and development of new drugs to the tune of $3.2 billion.

Chinese authorities are taking action to tackle illegal sales and marketing activities in the medical devices as they work to consolidate a market that remains chaotic.